Dyadic in deal to license biotechnology – Bizjournals.com
By Dr. Matthew Watson
 Bizjournals.com | Dyadic in deal to license biotechnology Bizjournals.com Emalfarb said he's working on a final license agreement with EnGen Bio, which is led by Mark R. Alfenito, a biotechnology veteran who has completed more ... Dyadic International Signs Term Sheet for Potential Exclusive Outlicense of C1 ...PR Newswire (press release) |
Uncategorized
Comments Off on Dyadic in deal to license biotechnology – Bizjournals.com |
June 10th, 2010
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research